Jan Christoph Brase

4PUBLICATIONS
56CO-AUTHORS
Gene and molecular therapyMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 25, 2026
Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in BRAF-Mutant Melanoma.

|Mar 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.

Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro

|Dec 01, 2023
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.

Daniel S W Tan, Enriqueta Felip, Gilberto de Castro

|Jan 14, 2022
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma.

Reinhard Dummer, Georgina V Long, Caroline Robert

Pageof 1

Frequent Collaborators

2 joint publications

Marina Chiara Garassino

2 joint publications

Rafael Caparica

2 joint publications

Keith T Flaherty

2 joint publications

Benjamin J Solomon